G
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A102.9 KBGlobal Blood Therapeutics, Inc.Feb 14, 8:34 AM ET·0001172661-23-000829
- SC 13G/A8.1 KBGlobal Blood Therapeutics, Inc.Feb 9, 10:59 AM ET·0000315066-23-001628
- 8-K235.2 KBGlobal Blood Therapeutics, Inc.Jun 6, 8:02 AM ET·0001171843-22-004158
- SC 13G/A10.6 KBGlobal Blood Therapeutics, Inc.Oct 12, 12:47 PM ET·0001274173-21-000103
- SC 13G/A13.8 KBGlobal Blood Therapeutics, Inc.Feb 10, 10:57 AM ET·0001104659-21-018179
- 8-K233.9 KBGlobal Blood Therapeutics, Inc.Oct 21, 8:00 AM ET·0001171843-19-006621
- 8-K17.6 KBGlobal Blood Therapeutics, Inc.Sep 19, 4:02 PM ET·0001193125-16-713415
- S-1/A2.0 MBGlobal Blood Therapeutics, Inc.Jun 20, 6:31 AM ET·0001193125-16-625609
- 44.6 KBGlobal Blood Therapeutics, Inc.Jan 7, 9:41 PM ET·0000899243-16-011355
- 45.5 KBGlobal Blood Therapeutics, Inc.Jan 4, 8:38 PM ET·0000899243-16-010702
Insiders
4Tickers
No tickers on record
Addresses
business
181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA, 94080
mailing
181 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA, 94080